ICICI Securities acted as the exclusive financial advisor for the transaction. AZB & Partners as legal counsel to ASG Eye Hospitals. Khaitan & Co. acted as legal counsel to Foundation Holdings and InvestCorp, Shardul Amarchand Mangaldas & Co acted as legal counsel to General Atlantic and Veritas Legal acted as legal counsel to Kedaara Capital
Read More
At a consolidated level, y-o-y revenues grew 23 per cent backed by robust growth in both Biosimilars (29 per cent) and Generics (19 per cent). Core EBITDA grew 25 per cent and margin improved to 31 per cent compared to 30 per cent in Q1FY22. and Net Profit grew 71 per cent to Rs 144 Crore
Read More
Under Sebi norms, listed companies are required to intimate the stock exchanges when their shareholding in an entity falls by 2 per cent or more
Read More
The first quarter results were against a strong quarter last year due to sales of COVID treatment, Remdesivir. Excluding the impact of Remdesivir, the underlying revenue from operations growth in the quarter was around 30 per cent year-on-year, the company informed in a statement
Read More
Both the firms have pledged up to Rs 300 crore towards setting up this centre, with the vision to provide paediatric medical and surgical services
Read More
The company plans to achieve USD 100 million annual revenue run rate in the next eight months
Read More
As per the company, they aim to utilise the funding to expand and deepen their presence in the Indian B2B healthtech industry
Read More
It is backed by Quadria Capital, a healthcare focussed private equity fund in Asia and KOIS
Read More
